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Abstract— In this work, the propagation of Asplin F strain of 
Newcastle disease virus (NDV) in DF-1 cells was investigated.  
Experiments were carried out in T-flask to investigate the effects 
of serum concentration in the culture medium during virus 
replication phase and multiplicity of infection (MOI) on virus 
production. Virus infectivity titre of 6.62 x 107 TCID50/ml was 
achieved when serum concentration of 0.5% and MOI of 20 was 
used. 
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I.  INTRODUCTION  
Newcastle disease (ND) is regarded as one of the 
most important disease in the poultry industry [1][25]. 
The disease which had its first outbreaks in in 1926, in 
Java, Indonesia [12], and in Newcastle-upon-Tyne, 
England [7] is highly contagious affecting 27 of the 50 
orders of birds [27]. Chickens are the most susceptible 
host, in which the severity of the disease may vary from 
mild infection with no apparent clinical signs to a severe 
form causing 100% mortality. The causative agent 
responsible for the disease is the Newcastle disease virus 
(NDV) [2]. NDV which is also known as avian 
paramyxovirus 1 is a member of the genus Avulavirus of 
the family Paramyxoviridae, in the order 
Mononegavirales [19]. This family also includes other 
important pathogens such as the mumps virus, human 
parainfluenza virus, sendai virus, simian virus 5 and 
recently emerging nipah and hendra viruses [13]. 
NDV strains are classified into three main 
pathotypes; lentogenic, mesogenic, and velogenic, based 
on the clinical signs and severity of the disease. 
Lentogenic strains cause mild or avirulent infections that 
are largely limited to the respiratory. Mesogenic strains 
are of intermediate virulence causing respiratory 
infection with moderate mortality while velogenic 
strains are highly virulent causing 100% mortality in 
chickens. Velogenic strains can be further categorized 
into two types: viscerotropic and neurotropic. 
Viscerotropic velogenic strains produce lethal 
hemorrhagic lesions in the digestive tract whereas 
neurotropic velogenic strains produce neurological and 
respiratory disorders [2][25].  
The disease caused by NDV remains a potential 
threat to commercial or backyard production until today. 
In 2002, an outbreak caused by a virulent strain of NDV 
occurred in California, USA. The outbreak has caused 
$200 million worth of losses from the depopulation of 
birds [11]. Although the disease is not yet eradicated, it 
can be controlled either by importing birds from disease 
free flocks or through vaccination that must continue 
throughout the life of the bird [19]. 
Currently, vaccines for ND are produced by using 
embryonated chicken eggs, a technology that has 
remained almost unchanged since the late 1930s. This 
traditional method however poses some drawbacks, such 
as the need for high amounts of specific pathogen-free 
eggs, high labor-intensity, time consuming and requires 
big area for the incubation of eggs. Besides the process 
is slow and difficult to scale-up, so large strategic stocks 
must be kept to respond in cases of epidemics [24]. An 
alternative to this method is the propagation of NDV in 
cell culture systems. It has been reported that Newcastle 
disease virus strains are able to replicate in an enormous 
range of cells [14]. Among cell substrate systems that 
have been identified are Vero cell, CEF cell and DF-1 
cell [5][6][22]. 
In the present work, the production of Newcastle 
disease virus (lentogenic Asplin F strain) in T-flasks 
using DF-1 cells as hosts was studied. The influence of 
factors such as serum concentration during virus 
replication phase and multiplicity of infection, MOI on 
virus yield was investigated. This study serves as the 
foundation for future live Newcastle disease vaccine 
production in larger cell culture systems such as the 
bioreactor.   
II. METHODOLOGY 
A. Cell line and virus strain 
Established DF-1 cell line (ATCC-CRL-12203) was 
purchased from the American Type Culture Collection 
(ATCC).  Lentogenic Asplin F strain of NDV was obtained 
from Malaysia Vaccine Pharmaceuticals (MVP) Sdn. Bhd. 
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B. Culture medium and chemicals 
Dulbecco‘s Modification of Eagle‘s Medium, DMEM 
(with glucose and L-glutamine) in powder form and fetal 
bovine serum (FBS) were supplied by Gibco®. 
C. Cell infection with NDV in T-flask 
Confluent monolayers of cells were used for infection with 
NDV as described by Hussain and Rasool [10]. Spent medium 
was removed and cell monolayer was washed with 5 ml of 
PBS. Later cells were infected with NDV according to the 
designed levels by inoculation of virus in DMEM 
supplemented with trypsin. The virus inoculums was spread 
uniformly and incubated in humidified CO2 incubator for 1 
hour with intermittent rotation to allow adsorption.  Five 
milliliters of maintenance medium with designed 
concentration of serum was added to flask. The flask was later 
returned to humidified CO2 incubator and monolayers were 
examined daily under inverted microscope for evidence of 
CPE. 
D. Virus harvesting 
The virus was harvested by combination of freeze thawing, 
sonication and centrifugation process. Four days post 
inoculation; flasks were transferred to -80°C freezer for 1 hour 
and later thawed at room temperature. This process was then 
resumed with sonication at 15°C for 1.5 minutes. 
Subsequently, virus suspensions were poured into centrifuge 
tubes and centrifuged at 300g for 10 minutes at 4°C to pellet 
the cell debris. The clear supernatant fluid containing virus 
was collected carefully, labeled and kept in -80°C freezer. 
E. TCID50 assay 
Fifty percent tissue culture infectious dose (TCID50) 
assay was carried out in 96 well flat shaped microtiter 
plates. Plates were seeded with DF-1 cells such that 
confluence was reached in 2–3 days. DF-1 cells were 
grown in DMEM media containing 10% FBS and grown 
at 37 °C, 5% CO2. Appropriate dilutions of each virus 
were prepared in DMEM medium and 100μl of each 
dilution was added to each well. Plates were incubated at 
37°C for 30–60 min before 100µL of DMEM was added 
to each well. The plates were then incubated for 4 days 
until the CPE effect was appeared. The log TCID50/ml 
calculation was based on the Reed and Muench [23] 
formula.  
F. Experimental design 
Optimization of NDV propagation in T-flask was carried 
out according to 3**(2-0) full factorial design (FD) generated 
by STATISTICA®. Two selected parameters; serum 
concentration and MOI were varied in this experiment to 
investigate their optimum value in response to virus infectivity 
titre produced. The design consists of 9 main runs, 4 replicates 
at the centre point and each parameter have 3 levels. The 
layout of the design is shown in Table 1. 
TABLE 1. 3**(2-0) Full factorial design for ndv propagation in T-flask 
 Level 
-1 0 1 
Serum concentration (%), A 0.5 1.5 2.5 
MOI, B 0.2 2 20 
III. RESULTS AND DISCUSSION 
A. Determination of time of infection (TOI) 
To propagate viruses in cell culture, a suitable time of 
infection (TOI) is required.  To this regard, the growth profile 
of DF-1 cell in the T-flask was studied and the appropriate 
time to infect with the virus was thereof determined.  
As shown in Figure 1, culture of DF-1 was started by 
inoculation of 1.00 x 105 cells/ml into the flask. Growth of DF-
1 cells were in lag phase from 0 hour until 48 hours. Starting 
from 48 hours, the culture entered exponential phase and 
reached the maximum cell concentration of 1.29 x 106 cells/ml 
at 64 hours. Once reached the maximum, cell concentration 
dropped and entered the death phase.  
Based on this, TOI was determined to be between 56 hours 
and 64 hours where the culture will be in the exponential 
phase. During this period, cells which will serve as the virus 
replication hosts are highly available and this will contribute 
to higher virus production. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.  Growth profile of DF-1 cell in T-flask 
Figure 2 shows the morphology of DF-1 cells before and 
after the infection by NDV. As can be observed, characteristic 
changes in the appearances of DF-1 cells were very obvious in 
which formation of giant multinucleated cell or syncytia, 
formation of plaques and also elongation of cytoplasmic tails 
has occurred after the infection. These changes are known as 
cytopathic effect or CPE. CPE is defined as pronounced 
morphologic changes induced in individual cells or groups of 
cells by virus infection, which are easily recognizable under a 
light microscope. CPE are very reproducible and can precisely 
character the virus type providing significant clues to the 
identity of a virus [4]. 
 
Figure 2.  Morphology of DF-1 cell in T-flask: (A) culture reached confluent 
state 64 hours after cell inoculation, (B) CPE showed by the culture 96 hours 
after the infection by NDV. 
B. Optimization of NDV production in T-flask 
Virus infection parameters, serum concentration 
during virus replication phase and multiplicity of 
 
A B 
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infection (MOI) as independent factors were optimized 
to yield high virus infectivity titre. Experiments were 
carried out as per the design matrix of the 3**(2-0) full 
factorial design (FD) (Table II), and the final virus titre 
produced by the culture was used as the response. For 
predicting the optimal values of virus titre obtained 
within the experimental constrains, a second order 
polynomial model was fitted to the experimental results 
by using the STATISTICA® software. The model 
developed is as follows:  
Y (Virus infectivity titre, TCID50/ml) = -- 8222414 + 
20301437(A) -- 2781034(A2) + 19951268(B) -- 
815773(B2) + 920045(AB)                                                                           
(1) 
where the virus infectivity titre as yield (Y) is a 
serum concentration (A), and MOI (B).           
The statistical model was checked by Fischer 
variance ratio, the F-value and the analysis of variance 
(ANOVA) for the response surface quadratic model is 
summarized in Table III. In Table III, the model F-value 
of 36.7793 implies that the quadratic regression model 
was significant. F-value is a statistically valid measure 
of how well the factors describe the variation in the 
mean of data. The greater the F-value from 1 the better 
the factors explain the variation in the data about its 
mean, and the estimated factor effects are real [17]. 
Model was further approved to be significant by having 
a very low probability value ((Pmodel > F) = 0.0001).  
At the model level, the correlation measures for the 
estimation of the regression equation are the correlation 
coefficient R and the determination coefficient R2. The 
correlation between the experimental and predicted 
values is better when the value of R is closer to 1[9][26]. 
In this experiment, the value of R and R2 were 0.98149 
and 0.96333 respectively. These values indicate a high 
degree of correlation between the experimental and the 
predicted values. The value of R2 indicates that 96.333% 
of the factors: serum concentration and MOI contribute 
very positively to the response. The value of R2 is also a 
measure of fit of the model and it can be mentioned that 
only 3.667% of the total variation were not explained by 
the virus infectivity titre. The value of the adjusted 
determination of coefficient was also very high 
(0.93714) which indicates high significance of the 
model.   
The P values are used as a tool to check the 
significance of each of the factors which, in turn, are 
necessary to understand the pattern of the mutual 
interactions between the factors. The lesser the P value 
than 0.05, the bigger the significance of the 
corresponding factor [16]. Based on this, the factors that 
were highly significant in the model were the MOI 
concentration (B), square terms of MOI (B2) and the 
interactive term between serum concentration and MOI 
(AB). Serum concentration (A) and its square term (A2) 
were not significant because their P values was larger 
than 0.05. However, in this study, all terms were 
included due to the significance of overall model. 
TABLE 2. Experimental design using 3**(2-0) full factorial design (FD) with 
experimental and predicted (using model equation) values of virus 
infectivity titre. 
 
Standard  
run 
Serum  
conc.  
(%) 
MOI Virus infectivity 
titre 
(TCID50/ml) 
   Experimental Predicted 
1 2.50000 2.00000 5.76 x 107 5.71 x 107 
2 1.50000 20.00000 5.89 x 107 6.10 x 107 
3 0.50000 0.20000 1.11 x 107 3.69 x 107 
4 0.50000 20.00000 6.62 x 107 6.47 x 107 
5 2.50000 0.20000 2.75 x 107 2.86 x 107 
6 1.50000 0.20000 1.48 x 107 1.96 x 107 
7 1.50000 2.00000 5.13 x 107 4.98 x 107 
8 0.50000 2.00000 2.95 x 107 3.69 x 107 
9 1.50000 2.00000 5.14 x 107 4.98 x 107 
10 1.50000 2.00000 5.11 x 107 4.98 x 107 
11 2.50000 20.00000 5.26 x 107 5.18 x 107 
12 1.50000 2.00000 5.12 x 107 4.98 x 107 
13 1.50000 2.00000 5.13 x 107 4.98 x 107 
 
TABLE 3 Analysis of Variance (ANOVA) for Response Surface Quadratic 
Model for optimization 
Source Sum of squares F value p value 
Model 3.520427 x 1015 36.7793 <0.0001 
Serum concentration, A 3.907699 x 1013 2.0413 0.196144 
MOI, B 2.575082 x 1015 134.5168 0.000008 
A
2
 2.136099 x 1013 1.1159 0.325900 
B
2
 1.474961 x 1015 77.0489 0.000050 
AB 4.059055 x 1014 21.2036 0.002470 
 
Figure 3 shows the virus infectivity titre predicted by the 
model and the real values obtained from the experiment.  
It can be observed that the point‘s distribution around the 
line for the response fitted to the linear model.   
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Figure 3.  Plot of observed versus predicted values for virus infectivity titre 
The 3D response surface plots described by the regression 
model were drawn to illustrate the effects of the independent 
factors and the interactive effects of each independent factor 
on the targeted response. The shape of the corresponding 2D 
contour plots indicates whether the mutual interactions 
between the independent variables are significant or not. An 
elliptical contour plots indicates that the interactions between 
the independent factors are significant. While a circular 
contour plot indicates that the interactions between related 
factors are negligible [17]. By analyzing the 3D response 
surface plots and the corresponding 2D contour plots, the 
optimal values of the independent factors could be observed, 
and the interaction between each independent factor can be 
easily understood [15]. Figure 2 shows elliptical contour plots 
since the interactive term between serum concentration and 
MOI, AB was significant (refer to Table 2). The maximum 
virus infectivity titre can be obtained at the point of 
intersection of the major and minor axes of the ellipse or by 
solving the inverse matrix of Eq. 1. By using STATISTICA®, 
the optimum values for each factor were determined; 1.79% 
for serum concentration and 11.22 for MOI which will yield 
the maximum virus infectivity titre of 1.22 x 108 TCID50/ml. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: 3D response surface and 2D contour plots shows the effect of 
serum concentration (%) and MOI on virus infectivity titre 
Genzel et al. [8] has reported that the multiplicity of 
infection (MOI) influences virus growth dynamics but not 
final virus yield. In the study of propagation of influenza virus 
in Vero and MDCK cells conducted by Audsley and Tannock 
[3], it has been observed that cells infected with higher MOIs 
maximum titers were attained earlier than in cultures infected 
at lower MOIs. While according to Maranga et al. [18] in his 
study of production of virus-like particles with a baculovirus 
insect cell system, he noticed that at high MOIs the specific 
productivity decreased when cells were infected at late growth 
phase. 
Different theories have encouraged us to investigate the 
effects of MOI on Newcastle disease virus production. As 
shown in Table II, three different MOIs, 0.2, 2.0 and 20 were 
used. Based on the result, the maximum virus infectivity titre 
of 6.62 x 107 TCID50/ml was achieved when we used high 
MOI, 20 (while serum concentration used was 0.5%). High 
MOI probably better suited NDV production in T-flasks. 
While for serum concentration during viral replication phase, 
it has been analyzed by STATISTICA® that the factor was not 
significant towards virus infectivity titre. In addition, serum 
was suggested to be removed from the culture medium to 
facilitate the growth of virus in the host cells [21].   
Apart from serum concentration and MOI, other factors 
such as type of cell, type of culture medium and time of 
infection also may partially contribute to the results we 
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obtained in this experiment. Investigation on their effects on 
virus production is much recommended.      
IV. CONCLUSION 
In the present work, two factors of interest for the 
establishment of a new platform for the production of 
Newcastle disease virus were investigated. It was 
verified by statistical analysis using STATISTICA®, 
that multiplicity of infection, MOI has substantial effect 
on the virus infectivity titre. High virus infectivity titre 
of 6.62 x 107 TCID50/ml was achieved when high MOI 
of 20 was used. Serum concentration during virus 
replication however was analyzed to have minor effect 
on the virus titre. Also it has been analyzed that the 
optimum conditions to produce Newcastle disease virus 
using DF-1 cell culture are serum concentration of 
1.79% and MOI of 11.22. These results constituted 
important information when large scale production of 
Newcastle disease virus is considered.  
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